Authors:
RUTKOWSKI B
CIOCALTEU A
DJUKANOVIC L
KISS I
KOVAC A
KRIVOSHIEV S
KVEDER R
POLENAKOVIC M
PURETIC Z
STANAITYTE M
TAREYEVA I
TEPLAN V
ZAVITZ J
Citation: B. Rutkowski et al., EVOLUTION OF RENAL REPLACEMENT THERAPY IN CENTRAL AND EASTERN-EUROPE 7 YEARS AFTER POLITICAL AND ECONOMICAL LIBERATION, Nephrology, dialysis, transplantation, 13(4), 1998, pp. 860-864
Authors:
RUTKOWSKI B
CIOCALTEU A
DJUKANOVIC L
KISS I
KOVAC A
POLENAKOVIC M
PURETIC Z
ROZENTAL R
STANAITYTE M
TAREYEVA I
TEPLAN V
ZAVITZ J
STEFAN K
RADO K
Citation: B. Rutkowski et al., TREATMENT OF END-STAGE RENAL-DISEASE IN CENTRAL AND EASTERN-EUROPE - OVERVIEW OF CURRENT STATUS AND FUTURE-NEEDS, Artificial organs, 22(3), 1998, pp. 187-191
Authors:
SCHUCK O
TEPLAN V
VITKO S
MATL J
SKIBOVA J
STOLLOVA M
Citation: O. Schuck et al., PREDICTING GLOMERULAR FUNCTION FROM ADJUSTED SERUM CREATININE IN RENAL-TRANSPLANT PATIENTS, International journal of clinical pharmacology and therapeutics, 35(1), 1997, pp. 33-37
Citation: V. Teplan et al., THE INFLUENCE OF ERYTHROPOIETIN (R-HU EPO) AND KETO AMINO-ACIDS (KA) ON LIPID-METABOLISM AND RENAL-FUNCTION TESTS IN CHRONIC-RENAL-FAILURE (CRF), Journal of the American Society of Nephrology, 7(9), 1996, pp. 3094-3094
Authors:
VALDERRABANO F
MADIAS NE
SCHENA FP
CARRERA F
SILVERBERG D
KOKOT F
ZUCCHELLI P
CANNATA J
ESCHBACH JW
MALLICK NP
SELVAGGI G
TEPLAN V
EFSTRATOPOULOS AD
CHANG JM
VISWESWARAN K
HURWICH B
PAPADIMITRIOU M
LASKER N
MATHEW T
Citation: F. Valderrabano et al., ERYTHROPOIETIN IN CHRONIC-RENAL-FAILURE, Kidney international, 50(4), 1996, pp. 1373-1391